Vol. 1 No. 06 (2025)

Articles

• β-Actin (ACTB): From Housekeeping Gene to Clinical Biomarker – Insights into Diagnostic, Prognostic, and Predictive Applications

  Dr Pravin Badhe (Author)

  01-10

  • PDF

• Pharmacovigilance and Real-World Evidence of ACTB-Linked Therapeutics in Breast Cancer: A Review

  Dr Pravin Badhe (Author)

  11-23

  • PDF

• Formulation Innovations Targeting ACTB Pathways in Breast Cancer: From Cytoskeletal Dysregulation to Precision Drug Delivery

  Dr. Pravin Badhe (Author)

  24-37

  • PDF

• Clinical Implications of ACTN4 in Oral Cancer: Biomarker for Prognosis and Therapeutic Targeting

  Dr Pravin Badhe (Author)

  38-46

  • PDF

• In-Vitro Evaluation of ACTB Modulation: Implications for Biomarker Discovery, Drug Response Prediction, and Overcoming Chemoresistance in Breast Cancer Models

  Dr Pravin Badhe (Author)

  47-55

  • PDF

• Formulation Innovations for EGFR-Targeted Breast Cancer Therapy: Enhancing Delivery and Efficacy

  Dr. Pravin Badhe, Ashwini Badhe (Author)

  56-64

  • PDF

• Pharmacovigilance in EGFR-Targeted Breast Cancer Therapy: Monitoring Safety Beyond the Bench

  Dr. Pravin Badhe, Ashwini Badhe (Author)

  65-80

  • PDF

• Intellectual Property Strategies for ACTB-Targeted Breast Cancer Therapies: How Patenting Supports Discovery, Formulation, and Clinical Translation of Inhibitors

  Dr. Pravin Badhe, Ashwini Badhe (Author)

  81-96

  • PDF